Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 301 - 350 out of 7,141

Document Document Title
WO/2009/084773A2
The present invention relates to a preparation process useful in synthesis of atorvastatin, more particularly a process for preparing atorvastatin is effective in treating hyperlipemia, comprising protecting the dihydroxy group at C3 and...  
WO/2009/084773A3
The present invention relates to a preparation process useful in synthesis of atorvastatin, more particularly a process for preparing atorvastatin is effective in treating hyperlipemia, comprising protecting the dihydroxy group at C3 and...  
WO/2009/080834A1
Process for the synthesis of a cyclic diester of an alpha-hydroxyacid, comprising the following steps: an alkalino-earth salt of the corresponding alpha-hydroxyacid is mixed with said alpha-hydroxyacid and water; the mixture is treated b...  
WO/2009/077385A1
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing...  
WO/2009/077615A1
The present invention relates to a method for obtaining lactide by thermal cracking of lactic acid oligomers in the presence of a metal salt of the phosphite anion (PO3)3- in which the metal is chosen from the group comprising tin, alumi...  
WO/2009/075818A1
Disclosed herein are methods and intermediates useful in the preparation of macrolides, e.g., compounds of formula (IV) wherein R1-R12 are as defined herein.  
WO/2009/076618A3
The present invention relates to, in part, novel sulfate and bisphenol compounds useful for the recognition, attachment and growth of unwanted biologies on natural and manmade surfaces. Another aspect of the invention relates to combinat...  
WO/2009/070910A2
Compounds of formula (I) wherein R1- R5, n and m have the same meaning as given in the description, having cooling properties are disclosed. Furthermore a process of their production and consumer products comprising them are disclosed.  
WO/2009/072502A1
Disclosed is a method by which various fluorine-containing carbonate compounds can be freely produced with high yield without using phosgene and without by-producing hydrogen chloride. Specifically disclosed is a method wherein a fluorin...  
WO/2009/070910A3
Compounds of formula (I) wherein R1- R5, n and m have the same meaning as given in the description, having cooling properties are disclosed. Furthermore a process of their production and consumer products comprising them are disclosed.  
WO/2009/072501A1
Disclosed is a novel method by which various carbonate compounds can be freely produced with high yield without using phosgene and without by-producing hydrogen chloride. Specifically disclosed is a method wherein a compound having a car...  
WO/2009/062224A1
The invention relates to a method for producing L,L-, D,D-, D,L- or meso-dilactide, comprising polycondensation and/or polytransesterification of L-, D- or D,L-lactic acid or esters thereof to form high-molecular-weight polyesters of L-,...  
WO/2009/065035A1
The invention provides novel therapeutic compounds, pharmaceutical compositions comprising these compounds, and methods for using these compounds and compositions to treat diseases and disorders, such as cancer.  
WO/2009/064031A1
There is provided a compound having an excellent controlling effect on pests, represented by the formula (I): wherein, A and E independently represent a -R1 group, a -L1-R1 group, etc.; G represents a -L2-R1 group, a -S(O)2-R4 group, etc...  
WO/2009/060832A9
Disclosed is a means for producing lactide efficiently in the production of a poly(lactic acid) by depolymerizing a lactic acid oligomer to produce lactide and ring-opening-polymerizing lactide. Also disclosed is a lactide production app...  
WO/2009/060832A1
Disclosed is a means for producing lactide efficiently in the production of a poly(lactic acid) by depolymerizing a lactic acid oligomer to produce lactide and ring-opening-polymerizing lactide. Also disclosed is a lactide production app...  
WO/2009/053250A1
The invention relates to compounds of the formula (I), in which the substituents have the meanings given in the description, method for producing said compounds, agents comprising the same, and the use thereof to combat damaging fungi.  
WO/2009/035951A2
Disclosed are amide, thioamide, urea and thiourea compounds and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and co...  
WO/2009/035951A3
Disclosed are amide, thioamide, urea and thiourea compounds and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and co...  
WO/2009/031437A1
Disclosed is a liquid crystalline compound which has stability to heat, light and the like, exhibits a nematic phase in a wide temperature range, has a low viscosity, adequate optical anisotropy and an adequate elastic coefficient K33, a...  
WO/2009/030396A1
The present invention relates to a method for the production or purification of biodegradable, intramolecular cyclic esters of alpha-hydroxycarboxylic acids, biodegradable alpha-hydroxycarboxylic acids or oligopolymers or polymers thereo...  
WO/2009/030330A1
The invention relates to a condensation and washing device which can recycle and clean, in particular, process steam that is produced during the production of polylactide. The invention also relates to a polymerisation device for produci...  
WO/2009/024492A1
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing...  
WO/2009/022311A3
The invention relates to 1,2-diamido-ethylene derivatives of the formula (I) wherein R1, R 2, R 3, and A are as described in the description and their use as medicaments, especially as orexin receptor antagonists.  
WO/2009/022311A2
The invention relates to 1,2-diamido-ethylene derivatives of the formula (I) wherein R1, R 2, R 3, and A are as described in the description and their use as medicaments, especially as orexin receptor antagonists.  
WO/2009/019561A3
The present invention is directed to a 2-deoxyribose-5-phosphate aldolase (DERA) chemoenzymatic process for making chiral compounds.  
WO/2009/019561A2
The present invention is directed to a 2-deoxyribose-5-phosphate aldolase (DERA) chemoenzymatic process for making chiral compounds.  
WO/2009/017261A1
The present invention relates to a method for preparing ultrafine p-dioxanone. The method comprises the steps of performing dehydrogenation cyclization of diethylene glycol in the presence of a pure silica catalyst (SiO ) or a copper-chr...  
WO/2009/010527A1
The present invention relates to a process for preparing cyclic glycerol acetals or cyclic glycerol ketals or mixtures thereof and cyclic glycerol monoester acetals or monoether acetals or cyclic glycerol monoester ketals or monoether ke...  
WO/2009/004990A1
It is intended to provide a prostaglandin F2α receptor agonist (FP receptor agonist), which comprises a biphenyl derivative represented by the following general formula (I) (wherein m represents an integer of 0 to 2; n represents an int...  
WO/2008/155818A1
A preventive or therapeutic agent for frequent urination and urinary incontinence containing as an active ingredient, a 1,4-benzodioxine derivative represented by the general formula (I): (wherein A represents an aryl group or a C3-8 cyc...  
WO/2008/150486A3
A compound is represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. A ...  
WO/2008/150486A2
A compound is represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. A ...  
WO/2008/148853A1
The present invention relates to novel compounds of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein: each R1 is independently selected from the group consisting of Cl, Br, CH3 and CF3; X is carbon or nitroge...  
WO/2008/145941A2
The invention relates to a conjugated process for the production of nitriles and/or of fatty amines and of polyol carbonates from a natural oil, comprising the following zones: I) zone of methanolysis or hydrolysis of a natural oil conta...  
WO/2008/145941A9
The invention relates to a conjugated process for the production of nitriles and/or of fatty amines and of polyol carbonates from a natural oil, comprising the following zones: I) zone of methanolysis or hydrolysis of a natural oil conta...  
WO/2008/145941A3
The invention relates to a conjugated process for the production of nitriles and/or of fatty amines and of polyol carbonates from a natural oil, comprising the following zones: I) zone of methanolysis or hydrolysis of a natural oil conta...  
WO/2008/139467A2
The present disclosure provides processes for the preparation of lipid conjugated cyclic carbonate derivatives. More specifically, the present disclosure is based on the finding that reacting lipids, such as, ceramides, with N,N'-disucci...  
WO/2008/139467A3
The present disclosure provides processes for the preparation of lipid conjugated cyclic carbonate derivatives. More specifically, the present disclosure is based on the finding that reacting lipids, such as, ceramides, with N,N'-disucci...  
WO/2008/136378A1
Disclosed is a compound represented by the following general formula: (wherein R1 represents a hydrogen atom or the like; R2 represents an optionally substituted alkyl or aryl group or the like; R3 and R4 may be the same or different and...  
WO/2008/134058A1
A dechalcogenative method for the preparation of an allylic sulfide comprises contacting an activated chalcogenide of Formula (I) with a thiol of Formula (II) for a period of time sufficient to form an intermediate of Formula (III), and ...  
WO/2008/125342A3
The present invention relates to novel vanilloid receptor ligands, a method for the production thereof, pharmaceuticals containing said compounds, and the use of said compounds for the production of pharmaceuticals.  
WO/2008/125342A2
The present invention relates to novel vanilloid receptor ligands, a method for the production thereof, pharmaceuticals containing said compounds, and the use of said compounds for the production of pharmaceuticals.  
WO/2008/118935A1
Processes and intermediates arc provided for the preparation of substituted aminomethyl 2,3,8,9-tctrahydiO-7H-1.4-dioxino[2.3-e]indo]-8-ones of the Formula (A) wherein the variables n, R and R3 are as described herein. Such compounds are...  
WO/2008/117305A3
The present invention provides process for the preparation of novel intermediates of (S)-Pregabalin. The present invention also provides process for the preparation of (S)-Pregabalin or a pharmaceutically acceptable salt or solvate there...  
WO/2008/117305A2
The present invention provides process for the preparation of novel intermediates of (S)-Pregabalin. The present invention also provides process for the preparation of (S)-Pregabalin or a pharmaceutically acceptable salt or solvate there...  
WO/2008/109601A2
The transient response of a switching power supply is improved by providing one or more supplemental power sources connected to the output terminal of the power supply. In one embodiment additional current is provided when a sudden incre...  
WO/2008/105286A1
Disclosed is a novel compound, namely a pentacyclic liquid crystal compound having a CF2O bonding group, which has general physical properties necessary for a compound, stability against heat and light, a wide temperature range of a liqu...  
WO/2008/102607A1
Disclosed is a method for the purification of a cyclic ester which comprises the steps of: mixing a co-effluent of a cyclic ester produced by the depolymerization with heating of a hydroxycarboxylic acid oligomer in the presence of a dep...  
WO/2008/089461A1
Specifically useful stereoisomers of 1,3-dioxane derivatives are described and their use in the treatment of a disease or condition dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders and inf...  

Matches 301 - 350 out of 7,141